Detalhe da pesquisa
1.
Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALK.
Am J Pathol
; 192(8): 1186-1198, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640677
2.
Bonded cumomer analysis of tumor metabolism based on 13 C magnetic resonance spectroscopy.
NMR Biomed
; 36(4): e4716, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196744
3.
Cell block-based RNA next generation sequencing for detection of gene fusions in lung adenocarcinoma: An institutional experience.
Cytopathology
; 34(1): 28-34, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36062384
4.
Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas.
Cancer Immunol Immunother
; 70(3): 869-874, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32857184
5.
Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma.
Blood
; 134(13): 1072-1083, 2019 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31331920
6.
Cutting Edge: ROR1/CD19 Receptor Complex Promotes Growth of Mantle Cell Lymphoma Cells Independently of the B Cell Receptor-BTK Signaling Pathway.
J Immunol
; 203(8): 2043-2048, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31534006
7.
Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.
Blood
; 132(1): 67-77, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29784639
8.
Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.
Blood
; 129(7): 823-831, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27879258
9.
Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases.
Blood
; 127(17): 2131-43, 2016 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26864341
10.
Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.
Blood
; 127(10): 1287-96, 2016 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26738536
11.
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy.
Blood
; 128(3): 360-70, 2016 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27166358
12.
Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome.
Blood
; 136(17): 1980-1983, 2020 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32518951
13.
Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.
Blood
; 124(5): 761-70, 2014 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-24957145
14.
Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent manner.
J Immunol
; 192(6): 2913-9, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24523507
15.
Distinct miRNA profile in prognosis of early CTCL.
Blood
; 131(7): 711, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29449300
16.
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma.
Blood
; 122(6): 943-50, 2013 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23801634
17.
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.
Blood
; 122(7): 1293-304, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23836560
18.
Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming.
J Immunol
; 191(12): 6200-7, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24218456
19.
The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4(+) T lymphocytes.
Am J Pathol
; 183(6): 1971-80, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24404580
20.
Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights.
Blood
; 130(23): 2569-2572, 2017 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29074500